From: The influence of gender on the effects of aspirin in preventing myocardial infarction
Source | Male (%) | Non–fatal MI | Fatal MI | Fatal and non-fatal MI |
---|---|---|---|---|
WHS [26] (2005) | 0 | 1.02 (0.83–1.25) | 1.17 (0.54–2.52) | 1.03 (0.84–1.25) |
PPP [19] (2001) | 42 | 0.69 (0.36–1.34) | 0.68 (0.19–2.40) | 0.69 (0.39–1.23) |
ACBS [18] (1995) | 45 | 1.71 (0.51–5.75) | NA | NA |
ETDRS [13] (1992) | 52 | NA | NA | 0.85(0.73–1.00) |
SAPAT [24] (1992) | 52 | 0.61 (0.43–0.87) | 1.02 (0.50–2.07) | 0.68 (0.50–0.92) |
HOT [23] (1998) | 53 | NA | NA | 0.85 (0.69–1.05) |
Swedish cooperative [8] (1987) | 62 | 0.88 (0.45–1.72) | 1.00 (0.33– 3.05) | 0.91 (0.52, 1.60) |
EAFT [14] (1993) | 63 | 0.94 (0.35–2.47) | 0.90 (0.52–1.56) | 0.91 (0.56–1.46) |
SALT [11] (1991) | 66 | 0.91 (0.59–1.41) | 0.65 (0.36–1.16) | 0.80 (0.57–1.13) |
Canadian group study [17] (1985) | 70 | 1.29 (0.49–3.36) | 0.54 (0.22–1.31) | 0.80 (0.43–1.48) |
SPAF [12] (1991) | 71 | 0.57 (0.19–1.70) | NA | NA |
Danish cooperative [27] (1983) | 73 | 0.25 (0.05–1.16) | 0.67 (0.20–2.31) | 0.43 (0.17–1.08) |
UK–TIA [22] (1991) | 73 | 0.86 (0.68–1.11) | 1.01 (0.74–1.39) | 0.92 (0.77–1.11) |
PARIS [5] (1980) | 77 | 0.68 (0.47–1.01) | 0.79 (0.55–1.15) | 0.74 (0.57–0.95) |
GAAT [16] (1980) | 78 | 0.63 (0.39–1.03) | 0.58 (0.30–1.12) | 0.61 (0.42–0.89) |
Cardiff–II [21] (1979) | 85 | 0.49 (0.33–0.75) | NA | NA |
AMIS [6] (1980) | 89 | 0.78 (0.63–0.96) | 1.08 (0.89–1.31) | 0.93 (0.81–1.07) |
Cardiff–I [20] (1974) | 100 | 0.68 (0.31–1.49) | NA | NA |
CDPA [7] (1980) | 100 | 0.86 (0.52–1.42) | NA | NA |
VACS [25] (1983) | 100 | 0.49 (0.29–0.81) | 0.17 (0.02–1.42) | 0.45 (0.28–0.74) |
PHS [9] (1989) | 100 | 0.61 (0.49–0.75) | 0.38 (0.19–0.80) | 0.58 (0.47–0.72) |
RISC [10] (1990) | 100 | 0.49 (0.33–0.73) | NA | NA |
TPT [15] (1998) | 100 | 0.68 (0.53–0.89) | 1.13 (0.78–1.63) | 0.81 (0.66–0.99) |
Total | 49 | 0.72 (0.64–0.81) | 0.88 (0.75–1.03) | 0.79 (0.72–0.87) |